Cover Image

Chinese herbal formula ruangan granule enhances the efficacy of entecavir to reverse advanced liver fibrosis/early cirrhosis in patients with chronic HBV infection: A multicenter, randomized clinical trial

Background: Nucleotide analogs treatment can reverse liver fibrosis in chronic hepatitis B (CHB). However, it has limited effect on fibrosis resolution in patients with CHB, particularly in preventing progression to hepatocellular carcinoma (HCC). Ruangan granule (RG), a Chinese herbal formula, has...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yufeng Xing (Author), Weichao Zhong (Author), Deti Peng (Author), Zhiyi Han (Author), Hua Zeng (Author), Yanqing Wang (Author), Lian Feng (Author), Jinzhen Huang (Author), Linyi Xu (Author), Mingtai Chen (Author), Daqiao Zhou (Author), Kaiping Jiang (Author), Xin Deng (Author), Hua Zhou (Author), Guangdong Tong (Author)
Format:	Book
Published:	Elsevier, 2023-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Tenofovir is superior to entecavir in reducing HCC for patients with HBV-related compensated cirrhosis at high HCC risk scores
by: Yan Huang, et al.
Published: (2022)

Plasmatic and intracellular concentration of entecavir during treatment of a symptomatic flare in HBV-HDV decompensated cirrhosis
by: Ilaria De Benedetto, et al.
Published: (2020)

Renal safety of tenofovir and/or entecavir in patients with chronic HBV monoinfection
by: Yang YM, et al.
Published: (2017)

HBV-Associated Cryoglobulinemic Vasculitis: Remission after Antiviral Therapy with Entecavir
by: Mauro Viganò, et al.
Published: (2014)

Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppressed HBV Replication in Mouse Model
by: Fei-lin Ge, et al.
Published: (2021)

Anti-Liver Fibrosis Activity and the Potential Mode of Action of Ruangan Granules: Integrated Network Pharmacology and Metabolomics
by: Xiaofei Shang, et al.
Published: (2022)

Comparative effectiveness of tenofovir versus entecavir in patients with hepatitis B virus-related cirrhosis in Taiwan: a retrospective cohort study
by: Yu-Han Huang, et al.
Published: (2023)

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective
by: Tsai N, et al.
Published: (2012)

Cortical Signature of Patients with HBV-related Cirrhosis without Overt Hepatic Encephalopathy: a Morphometric Analysis
by: Xiu eWu, et al.
Published: (2015)

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity
by: Si-Yu Yuan, et al.
Published: (2022)

FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
by: Xiao-Jie Lu, et al.
Published: (2020)

Is increasing the dose of Entecavir effective in partial virological responders?
by: Erturk A, et al.
Published: (2014)

Entecavir: A Review and Considerations for Its Application in Oncology
by: Tânia Lourenço, et al.
Published: (2023)

RANCANG BANGUN KONTROL RUANGAN PORTABLE
by: Budiyono, Anton
Published: (2017)

Analysis of Risk Factors for Development of Hepatocellular Carcinoma in Chronic HBV - Infected Liver Cirrhosis Patients: A Meta-Analysis
by: Xiang Lyu, et al.
Published: (2017)

The Levels of Ghrelin, Leptin, TNF-α, and IL-6 in Liver Cirrhosis and Hepatocellular Carcinoma due to HBV and HDV Infection
by: Huseyin Ataseven, et al.
Published: (2006)

Analisis Faktor Gaya kepemimpinan Kepala Ruangan terhadap Kinerja Perawat di Ruangan Rawat Inap Kelas 3
by: Redo Widhio Mahatvavirya, et al.
Published: (2021)

Clinical utility of entecavir for chronic hepatitis B in Chinese patients
by: Wang JY
Published: (2013)

Validated spectrometric determination of penciclovir and entecavir in bulk and in pharmaceutical preparations
by: Asmaa A. Elzaher, et al.
Published: (2016)

PEMBUATAN ALAT PENGATUR SUHU RUANGAN OTOMATIS
by: Daenur Hidayat, -
Published: (2007)

Cost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance
by: Wang G, et al.
Published: (2015)

Entecavir Treatment in Children and Adolescents with Chronic Hepatitis B Virus Infection
by: Kai-Chi Chang, et al.
Published: (2016)

ANALISIS PERBEDAAN EFEKTIFITAS MEDIA INTERPRETASI DI MUSEUM GEOLOGI BANDUNG : Studi kasus : Ruangan Sejarah Kehidupan dan Ruangan Geodigi
by: Ramadhan, Prima Charismaldy
Published: (2014)

Integrating network analysis and experimental validation to reveal the mitophagy-associated mechanism of Yiqi Huoxue (YQHX) prescription in the treatment of myocardial ischemia/reperfusion injury
by: Mingtai Chen, et al.
Published: (2023)

Influencing factors and prediction models for AKI in ascites patients with hepatitis B cirrhosis
by: Xue-qian Chu, et al.
Published: (2024)

HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in Southeast China
by: Yueming Chen, et al.
Published: (2012)

The efficacy of pegylated interferon alpha-2a and entecavir in HBeAg-positive children and adolescents with chronic hepatitis B
by: Yi He, et al.
Published: (2022)

HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in South-east China
by: Yueming Chen, et al.
Published: (2012)

Constipation during Entecavir treatment in Chronic Hepatitis B patients: Two Cases Reports
by: Meng-Lan Wang, et al.
Published: (2017)

Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B
by: Beatriz López Centeno, et al.
Published: (2016)

A glycoengineered therapeutic anti-HBV antibody that allows increased HBsAg immunoclearance improves HBV suppression in vivo
by: Min You, et al.
Published: (2023)

The effects of the insulin resistance index on the virologic response to entecavir in patients with HBeAg-positive chronic hepatitis B and nonalcoholic fatty liver disease
by: Zhu LY, et al.
Published: (2016)

IMPLEMENTASI LOGIKA FUZZY PADA SISTEM PEREDUP LAMPU OTOMATIS RUANGAN
by: Arif Muhammad Shidiq, -
Published: (2019)

Ruangan khas deklamasi denotatif deklamasi konotatif / Abdul Ghafar Ibrahim
by: Ibrahim, Abdul Ghafar
Published: (2006)

Peningkatan Kepuasan dan Kinerja Perawat Melalui Supervisi Kepala Ruangan
by: Estelle Lilian Mua, et al.
Published: (2011)

Association of hepatitis B virus treatment with all-cause and liver-related mortality among individuals with HBV and cirrhosis: a population-based cohort studyResearch in context
by: Jean Damascene Makuza, et al.
Published: (2024)

Effects of Fuzheng Huayu recipe on entecavir pharmacokinetics in normal and dimethylnitrosamine-induced hepatic fibrosis rats
by: Tao Yang, et al.
Published: (2020)

Enrichment of Ly6Chi monocytes by multiple GM-CSF injections with HBV vaccine contributes to viral clearance in a HBV mouse model
by: Weidong Zhao, et al.
Published: (2017)

Comprehensive investigation of HBV-related hepatocellular carcinoma and choice of anti-HBV therapy
by: Huihui Lu, et al.
Published: (2021)

The unique antibody suppresses HBV viremia and reduces hepatocarcinogenesis in HBV-transgenic mice
by: Xiao-Zhen Kang, et al.
Published: (2018)